Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
UCB is a global biopharmaceutical company headquartered in Belgium. It focuses on the research and development of innovative medicines for patients with severe diseases in immunology and neurology to sustainably improve their quality of life.
Date confirmed from the company's own financial calendar.
UCB is scheduled to report its next quarterly earnings on 02/25/2027.
UCB last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 6.84 EUR.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.